BD beats The Street in Q1, raises 2023 guidance
BD today posted first-quarter financial results that topped the consensus forecast and included increased full-year guidance.
Stay updated with breaking news from Massdevice Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BD today posted first-quarter financial results that topped the consensus forecast and included increased full-year guidance.
Align Technology (Nasdaq:ALGN) this week announced Q4 results that beat the overall consensus on Wall Street.
Overall, Cardinal Health's second-quarter results beat the consensus on Wall Street. It upped its full-year EPS guidance.
Boston Scientific shares rose before the market opened today on fourth-quarter results that came in mixed compared to the consensus forecast.
A federal appeals court rejected Johnson & Johnson's complex legal maneuver to shield itself from liability in talc-related lawsuits.